check_circleStudy Completed

Multiple Sclerosis

"BRIGHT" (Betaferon® vs. Rebif® Investigating Higher Tolerability) Observational Study to assess Injection Site Pain in Multiple Sclerosis patients

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
454
Trial Dates
June 2004 - February 2006
Phase
N/A
Could I Receive a placebo
N/A
Products
Betaseron (Interferon beta-1b, BAY86-5046)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation

Primary Outcome

Secondary Outcome

Trial design

"BRIGHT"(Betaferon® vs. Rebif® Investigating Higher Tolerability) Observational Study to assess Injection Site Pain in Multiple Sclerosis patients treated with Betaferon® vs. Rebif®
Trial Type
Observational
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A